Sequenom Forms In-Network Contracts
News May 04, 2016
Sequenom, Inc. has entered into agreements with Blue Cross and Blue Shield of Georgia, Inc. (effective 4/11/16), Anthem Blue Cross and Blue Shield Health Plans for Indiana, Kentucky, Missouri, Ohio and Wisconsin (effective 5/15), and Anthem Blue Cross and Blue Shield in Virginia (effective 5/23/16).
The agreements provide in-network coverage for Sequenom Laboratories™' noninvasive prenatal tests for both high and average-risk pregnancies to Anthem's members in those states. The Georgia agreement does not include HMO plans, and the Virginia agreement does not include HealthKeepers products.
"Becoming an in-network provider with leading health insurers, particularly for average risk pregnancies, is a critical component of our commercialization plan," said Dirk van den Boom, Ph.D., President and CEO of Sequenom. "The addition of these seven states to our Anthem Blue Cross and Blue Shield relationship represents meaningful progress in our efforts to bring the benefits of noninvasive prenatal testing to women throughout the United States."
Specific Set of Nerve Cells Controls Seizures’ Spread Through BrainNews
This discovery could lead to new and better treatments for epilepsy.READ MORE
Classification Can Lead to New Ways to Diagnose CancerNews
A novel approach to studying cancer has enabled researchers to group about 10,000 human cancers of 32 different types into 10 classes based on the molecular pathways that drive tumor growth.READ MORE
New Technology Enables Identification of Biomarkers for a Wide Range of DiseasesNews
Scientists have developed a way to identify biomarkers for a wide range of diseases by assessing the antibodies we are making to the complex sugars coating our cells.READ MORE